Ati cautat: pacienti in stadiul terminal
Protocol terapeutic: A10BD10 – DCI COMBINAĊ˘II (SAXAGLIPTINUM + METFORMINUM) – concentraĊ£ia 2,5 mg/1000 mg (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A10BH03 – DCI SAXAGLIPTINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N022G – DCI GALANTAMINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N021G – DCI RIVASTIGMINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N020G – DCI DONEPEZILUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: N001F – DCI MEMANTINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A022E – DCI SITAGLIPTINUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Boala cronica de rinichi afecteaza 10-15% din populatie si procentul este in crestere
